Conception and design: James T. Topham, Hagen F. Kennecke, Derek J. Jonker, Eric X. Chen, Jonathan M. Loree
Financial support: Jonathan M. Loree
Provision of study materials or patients: Hagen F. Kennecke, Derek J. Jonker, Eric X. Chen, Jonathan M. Loree
Collection and assembly of data: James T. Topham, Young S. Lee, Weimin Li, Katie Quinn, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree
Data analysis and interpretation: James T. Topham, Harriet Feilotter, Weimin Li, Kimberly C. Banks, Katie Quinn, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree
Manuscript writing: All authors
Final approval of manuscript: All authors
Accountable for all aspects of the work: All authors
AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Harriet Feilotter
Honoraria: Janssen Diagnostics, Roche Canada, Precision RxDx, Bristol Myers Squibb, Diaceutics, Astellas Pharma, Bayer, EMD Serono, Novartis Canada Pharmaceuticals Inc, AstraZeneca, Pfizer
Consulting or Advisory Role: Janssen Diagnostics, Roche Canada, Precision RxDx, Astellas Pharma, Bayer
Speakers' Bureau: Bayer, EMD Serono, AstraZeneca
Research Funding: AstraZeneca (Inst), Bayer (Inst), EMD Serono (Inst), Delphi Diagnostics (Inst), Lilly (Inst), Amgen (Inst), Roche Canada (Inst)
Hagen F. Kennecke
Honoraria: Natera, Tersera, Novartis
Consulting or Advisory Role: Tersera
Speakers' Bureau: Natera
Research Funding: Taiho Pharmaceutical (Inst), Novartis (Inst), Exelixis (Inst)
Young S. Lee
Employment: AstraZeneca
Stock and Other Ownership Interests: AstraZeneca
Weimin Li
Employment: Overland Pharmaceuticals, Takeda
Stock and Other Ownership Interests: Overland Pharmaceuticals, Takeda
Kimberly C. Banks
Employment: Guardant Health
Stock and Other Ownership Interests: Guardant Health
Patents, Royalties, Other Intellectual Property: Guardant Health
Katie Quinn
Employment: Guardant Health
Stock and Other Ownership Interests: Guardant Health
Daniel J. Renouf
Honoraria: Roche, Bayer
Consulting or Advisory Role: Roche
Research Funding: Bayer (Inst), Roche (Inst)
Eric X. Chen
Honoraria: Eisai, Roche Canada, Bayer, AstraZeneca Canada, Ipsen
Research Funding: Merck Sharp & Dohme, AstraZeneca/MedImmune, Bristol Myers Squibb, Novartis, Mirati Therapeutics, Roche Canada, 1Globe Health Institute, Repare Therapeutics, Nubiyota
Jonathan M. Loree
Consulting or Advisory Role: Taiho Pharmaceutical, Ipsen, Novartis, Bayer, Amgen, Eisai, Pfizer
Research Funding: Ipsen (Inst), Amgen (Inst)
No other potential conflicts of interest were reported.
留言 (0)